Advertisements

Prospan Cough Syrup

Quick links to important sections

Prospan Cough Syrup

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Prospan Cough Syrup

Property Description
Active ingredient Dried Ivy Leaf Extract (Hedera helix L.)
Form Syrup (Oral Liquid)
Pharmacological class Expectorant and Mucolytic
Common use Productive (chesty) cough
Origin Natural (Phytopharmaceutical)

Prospan Cough Syrup is defined as a herbal medicinal product presented as an oral liquid preparation, intended for the symptomatic management of coughs accompanied by excessive mucus production. Its active component is Dried Ivy Leaf Extract, which is meticulously standardized as the proprietary extract EA 575. This standardization is clinically recognized for ensuring a consistent level of the active triterpene saponins, including Hederacoside C and its metabolite, α-hederin.

Its classification by regulatory bodies places it in the pharmacological class of an expectorant and a mucolytic agent. A distinguishing feature of Prospan is its focused formulation as a single-ingredient phytopharmaceutical, which contrasts with many combination cough and cold products. The preparation is manufactured and distributed internationally by Engelhard Arzneimittel, and many versions are formulated to be alcohol-free and, frequently, sugar-free, making them generally suitable for a wide patient demographic.

The general therapeutic purpose of the product is to help the body effectively manage a cough characterized by the accumulation of thick mucus, such as during a common cold. Its action is designed to be secretolytic and expectorant, which facilitates the thinning and mobilization of bronchial secretions. This mechanism is intended to help make the secretions thinner and easier to clear from the lungs, ultimately aiding the patient in achieving a more efficient and less irritating cough.

Regulatory References

  1. EMA Herbal Monograph on Hedera helix
  2. EMA Monograph on Ivy Leaf
Advertisements

What side effects are possible with Prospan Cough Syrup?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of the Dried Ivy Leaf Extract preparation as formally documented in regulatory sources.


Adverse Reaction Scope

The most frequently documented adverse reactions fall into the categories of Gastrointestinal disorders and Immune system disorders (hypersensitivity).

Classification Affected System(s) Example Reactions (as per regulatory documents)
Common (1 to 10 users in 100) Gastrointestinal disorders Nausea, Vomiting, Diarrhea
Uncommon (1 to 10 users in 1,000) Immune/Skin disorders Rash, Urticaria (Hives), Dyspnea (Shortness of breath)

Serious Adverse Reactions: The officially documented adverse reactions classified under Uncommon include severe allergic manifestations such as dyspnea and angioedema (swelling of the face or throat). While these are rare, their documentation emphasizes the potential for a severe systemic allergic response.

Safety-Related Restrictions: The product is contraindicated (should not be used) in individuals with a known hypersensitivity or allergy to the active ingredient, Dried Ivy Leaf Extract (Hedera helix L.), or to any plants of the Araliaceae family.

Context-of-Use Safety Notes: Regulatory labeling advises that if symptoms worsen, or if additional symptoms such as fever, purulent sputum, or difficulty breathing (dyspnea) occur, further medical evaluation is necessary. Some official documentation advises caution for patients with a history of gastritis or stomach ulcers, aligning with the potential for common gastrointestinal side effects.


Connection to the Official Safety Profile

The regulatory safety profile establishes that the primary expected adverse reactions are Common gastrointestinal issues due to the saponin content of the extract. The framework highlights that the main clinically significant risk is the potential for Uncommon but serious hypersensitivity events. This structure defines the two primary physiological systems—gastrointestinal and immune—as the core safety domains and establishes clear limitations on use for allergic individuals.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

This section is based on official government regulatory statements regarding overdose risks and required emergency actions for products containing Dried Ivy Leaf Extract.


Overdose Scope

Element Regulatory Statement
Documented overdose presentations Acute gastrointestinal distress, including nausea, vomiting, and diarrhoea. In some instances, agitation has been reported.
Emergency-response statements The mandated action following an overdose is to consult a doctor or a pharmacist. Management is officially described as symptomatic treatment.
Population-specific overdose notes Children under two years of age may require careful monitoring due to the risk of aggravating respiratory symptoms and the development of gastrointestinal adverse effects.

Overdose Classifications

Element Regulatory Statement
Severity classification Overdose manifestations primarily involve acute but typically non-life-threatening gastrointestinal effects.
Overdose-context constraints No specific antidote is mentioned in the official regulatory labeling for the management of the overdose.

Official Overdose Statements

  • Ingesting doses significantly higher than recommended may result in acute gastrointestinal manifestations and, potentially, central nervous system effects such as agitation.
  • Following the intake of doses larger than those recommended, consultation with a doctor or a pharmacist is explicitly required for assessment and care.

Connection to the Overall Overdose Profile

Regulatory documents define the official overdose profile based on documented acute gastrointestinal manifestations that occur after exceeding the prescribed dose. The guidance for help-seeking is defined as mandatory consultation with a healthcare professional for symptomatic management, which reflects the absence of a known specific antidote or documented life-threatening severe outcomes in the labeling.

Advertisements

Therapeutic Uses of Prospan Cough Syrup

The product is used in areas where additional symptomatic support is needed for coughs that involve excessive or difficult-to-clear mucus. It is applied across domains where short-term symptomatic assistance is appropriate due to respiratory secretions.

Ivy leaf preparations are recognized as an expectorant for productive (chesty) coughs.

The product is relevant in conditions characterized by periods of heightened symptoms in the respiratory tract, such as conditions involving acute or episodic manifestations like the common cold, acute bronchitis, and is applied when appropriate in contexts involving chronic bronchial manifestations. This product is used for managing symptoms related to a wet, chesty cough and difficulty clearing the airways. It supports patients during difficult episodes by easing distress related to chest congestion and may assist with maintaining a sense of stability for adults, adolescents, and children.

Quick Fact: Relief for Productive Cough
Symptom Focus: Difficult expectoration and chest congestion.
Therapeutic Context: Applied in situations involving acute or episodic symptoms.
Patient Benefit: Provides support that helps ease the overall symptom burden and contributes to improved comfort.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Prospan Cough Syrup?

The population eligibility for Prospan Cough Syrup, which contains Dried Ivy Leaf Extract, is determined by strict rules set forth in regulatory product labeling.

Populations for Whom Use is Established

The medicine is documented for established use in adults and older adults. For younger age groups, the standard regulatory position permits use in adolescents (12 years of age and over) and children from the age of two years and older.

Absolute Contraindications

The medicine must not be used in certain groups as defined by official regulatory authorities:

  • Children under 2 years of age are absolutely contraindicated. The prohibition is due to the potential risk of aggravating respiratory symptoms when using secretolytic drugs in this age group.
  • Individuals with known hypersensitivity (allergy) to the active substance, ivy leaf (Hedera helix L.), or to other plants in the Araliaceae family must not use the product.

Restricted and Not Recommended Use

Certain physiological states and pre-existing conditions impose restrictions or require professional consultation:

  • Pregnancy and Lactation: Use during both pregnancy and breastfeeding is not recommended. This limitation is due to the absence of sufficient safety data in these populations.
  • Comorbidities: Caution is required in patients with a history of gastritis or gastric ulcer; these individuals must seek medical advice prior to use.
  • Excipient Restriction: Patients with diagnosed hereditary fructose intolerance should not take the syrup formulation due to its sorbitol content.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Dried Ivy Leaf Extract, the active component in Prospan Cough Syrup, is defined by a specific caution related to pharmacodynamic effects and a general statement concerning the absence of documented pharmacokinetic interactions.

Interaction Classification Official Regulatory Finding
Pharmacodynamic Caution Non-recommended concomitant use with certain agents.
Metabolic / Transport None documented; no formal interaction studies have been performed.

The primary restriction listed in official labeling is the non-recommended concomitant use of the syrup with certain cough-suppressant medicines. This interaction-related constraint applies to antitussives such as Codeine and Dextromethorphan. This caution relates to the potential for the expectorant action of the product to conflict with the mechanism of centrally-acting cough suppressants.

The interaction profile is consistently defined by the explicit regulatory statement that no studies have been performed to assess the effects of Dried Ivy Leaf Extract on the metabolism of other medicines, including those mediated by CYP enzymes. Consequently, official documents list no known substances that would alter the drug's clearance or exposure. The official documentation also contains no mandatory rules for separating the administration of this product from any other medicine by a specific time interval. The overall finding is that no adverse effects are known when this product is taken alongside other medicines.

Advertisements

Mechanism of Action

The Dried Ivy Leaf Extract (EA 575), via its active metabolite alpha-hederin, exerts its effects through two primary pharmacodynamic mechanisms.

Modulation of Bronchial beta2-Adrenergic Receptors

The active metabolite acts as an indirect inhibitor of the enzyme G Protein-Coupled Receptor Kinase 2 (GRK2). By inhibiting GRK2, the molecule reduces the phosphorylation and subsequent desensitization of beta2-adrenergic receptors (beta2-AR) on bronchial smooth muscle cells. This receptor modulation results in the sensitization of the beta2-ARs, increasing the responsiveness to endogenous catecholamines. This physiological change promotes the relaxation of bronchial smooth muscle, resulting in increased bronchial lumen diameter.

Activation of the Secretolytic Vagal Reflex

The saponin components initiate a systemic response by stimulating vagal afferent terminals located in the gastrointestinal tract. This triggers a parasympathetic reflex that increases the efferent nervous system output to the lungs. This reflex action targets the submucosal glands in the bronchi, promoting the secretion of a higher volume of serous fluid. This physiological consequence leads to the dilution and decreased viscosity of bronchial secretions, supporting the process of mucociliary clearance.

Advertisements

Dosage and Administration Information

How to use Prospan Cough Syrup: Official Administration Guidelines

The usage protocol for Prospan Cough Syrup, a herbal medicinal product containing Dried Ivy Leaf Extract (Hedera helix L.), is structured by specific instructions established for the product. Administration is approved exclusively for oral ingestion.

Dosing and Frequency Patterns

The required dose volume is dependent upon the age of the patient and follows a multiple-dose-per-day frequency pattern. For Adults and Adolescents (12 years and over), the typical single dose ranges from 5 mL to 7.5 mL, generally administered three times daily. For Children between 6 and 12 years of age, the standard single dose is typically 5 mL, administered up to three times daily. A lower volume of 2.5 mL is established for Younger Children (2 to 6 years), administered two to three times daily.

Preparation and Course Duration

Preparation for administration requires the container to be shaken well immediately before each use to ensure product homogeneity. Dosing accuracy is mandatory and requires the use of the enclosed measuring cup provided with the product. The intake timing is flexible, as the product may be administered regardless of food consumption.

Regarding the use over time, the administration should be maintained for a period of at least one week. Furthermore, it is specified that use should be continued for an additional two to three days after the symptoms have subsided to support comprehensive resolution.

If a scheduled dose is missed, it must be administered immediately unless it is almost time for the next dose, in which case the forgotten dose is skipped; a double dose must not be taken to compensate.

Advertisements

Recent Clinical Evidence

Prospan Cough Syrup: Recent Clinical Evidence


Evidence for Acute Productive Cough

Research exploring how symptoms change over time when Dried Ivy Leaf Extract EA 575 is used has been conducted in short-term Randomized Controlled Trials (RCTs) and large Non-Interventional Studies (NIS) for acute cough characterized by excessive mucus. The core research base examined outcomes related to physical discomfort and outcomes reflecting daily functioning using standardized assessments like the Bronchitis Severity Score (BSS) and Visual Analogue Scale (VAS). These patient-reported outcomes were the main focus. Studies report how symptoms evolved in the observed populations during the study period. This evidence contributes to understanding symptom patterns, which is part of the regulatory review process for classifying the product's use in conditions associated with acute or disruptive episodes.


Chronic Manifestations and Follow-up Periods

The extract was also studied in research contexts involving conditions that may involve periods of heightened symptoms in the bronchi over a longer time. The evidence for this use relies on older, controlled clinical studies and extensive bibliographic data documenting its long-standing clinical application. This literature was reviewed by regulatory authorities, which was part of the evidence used to support a classification of "well-established use" in certain regions. In general, the follow-up durations were limited in most randomized trials (typically around seven days). Long-term effects are not fully established by current controlled research, meaning limited information for long-term outcomes is available.


Evidence Gaps and Special Age Groups

The extract was evaluated in a range of age groups, including adults, adolescents, and children. However, the evidence quality varies across studies when comparing adults to children. Data for certain groups remain insufficient when compared to large-scale adult RCTs, as some pediatric efficacy trials used observational settings and had modest sample sizes. Further limitations highlight that comparative evidence against all other available cough therapies is lacking, and subgroup findings are uncertain for many comorbid conditions.

Key Studies & References Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Prospan Cough Syrup (FAQ)

Q: Does Prospan Cough Syrup contain any alcohol or sugar?

A: Official product information confirms that the standard Prospan syrup is generally formulated to be alcohol-free and sugar-free. However, it does contain the sweetener sorbitol. This substance is a sugar substitute that, in some individuals, may lead to a mild laxative effect.

Q: Can Prospan Cough Syrup be taken by people with diabetes?

A: According to the official product information, the syrup is formulated without sugar. However, it contains the excipient sorbitol, which is a sugar substitute. Official guidance indicates that individuals managing diabetes should discuss the product's sorbitol content with a healthcare professional.

Q: How does the ivy leaf extract in Prospan supposedly affect the cough reflex?

A: Official documents describe the active ingredient as having both a mucolytic (mucus-thinning) and bronchodilatory (airway-relaxing) action. By thinning the mucus and widening the airways, the body can more easily move and clear the bronchial secretions. This process facilitates a more efficient and less irritated cough.

Q: Can Prospan be taken with a multivitamin or herbal supplement?

A: Official product information indicates that no known adverse effects have been reported when Prospan is taken alongside other medicines. While formal studies on interaction with every multivitamin or herbal supplement are not available, regulatory sources list no known restrictions or contraindications regarding co-administration.

Q: What if I experience a mild side effect—should I stop taking Prospan?

A: Official regulatory guidance advises that if your cough symptoms worsen, or if you experience serious allergic reactions such as swelling or difficulty breathing, professional medical evaluation is necessary. For common or mild side effects, like temporary stomach upset, regulatory guidance recommends consulting a pharmacist or healthcare provider for guidance.

Q: Is there evidence that Prospan works differently for children versus adults?

A: Regulatory reviews note a difference in the types of studies conducted for various age groups. For example, evidence quality for children may vary compared to the larger randomized trials conducted in adults. This difference in study design means the certainty of the evidence is not identical across all populations.

Q: Why is the official guidance on use typically limited to a specific number of days?

A: Official guidance on the duration of use is linked to the extent of the available clinical evidence. Most controlled studies examining the product’s effects were conducted over relatively short timeframes, typically around one week. Therefore, regulatory texts state that the long-term effects of the extract are not fully established by current controlled research.

Q: Is Prospan Cough Syrup the same as other ivy leaf extract cough medicines?

A: Official product information indicates that Prospan contains the specific standardized extract EA 575. The manufacturing and process for this extract are proprietary. This proprietary standardization differentiates Prospan from other cough medicines that may also use generic ivy leaf extracts.

Q: Is it safe to drive or operate machinery after taking Prospan?

A: According to regulatory and product information, Prospan is officially described as a non-drowsy formulation. This suggests that the product does not typically affect alertness or reaction time, according to regulatory information.

Q: Is Prospan safe to use if I have asthma or other respiratory conditions?

A: Official product warnings include specific contraindications for allergies and age limits, as well as cautions for patients with a history of gastritis or stomach ulcers. No specific contraindications or cautions regarding asthma or other pre-existing chronic respiratory conditions are noted in the product's regulatory safety profile.

Q: Does Prospan help with coughs caused by allergies?

A: The product's mechanism of action targets coughs associated with respiratory tract diseases, providing mucolytic and bronchodilatory support. Allergic cough is not an officially listed indication. Its purpose is focused on symptomatic treatment of productive coughs related to excessive mucus.

Q: Is Prospan Cough Syrup known to cause drowsiness?

A: Regulatory and official product information states that Prospan is formulated to be non-drowsy. No central nervous system effects such as sleepiness are listed among the common or uncommon side effects.

Q: Does Prospan contain any common allergens like gluten or lactose?

A: Official product information specifies that the syrup formulation is commonly described as being free from gluten and lactose. This distinction is relevant for individuals with specific dietary intolerances or allergies.

Q: Does the color or consistency of the syrup mean anything about its quality?

A: Because the product is derived from a plant extract, some natural variation in the syrup’s color, taste, or consistency can occur. Official documents explicitly state that these minor differences due to the natural origin do not affect the quality of the preparation.

Q: Are there any warnings about overdose or taking too much Prospan?

A: Official regulatory documents include a statement on overdose. Taking too much of the product can provoke adverse reactions, primarily affecting the gastrointestinal system, such as nausea, vomiting, and diarrhea, along with possible agitation.

Q: Does Prospan contain preservatives?

A: Official documents related to the product’s composition list excipients such as Sodium benzoate and Potassium sorbate. These ingredients are commonly included in liquid formulations and function as preservatives to maintain the stability and shelf life of the syrup.

Advertisements

How should Prospan Cough Syrup be stored and disposed of?

How to Store and Dispose of Prospan Cough Syrup?

The storage and disposal of Prospan Cough Syrup must follow official regulatory guidelines to maintain its stability and ensure environmental safety.

Storage Requirements

The syrup must be stored below 25 C in its original bottle, which must be kept tightly closed. It is mandatory to keep the medicine out of the sight and reach of children. Do not use the product past its printed expiry date.

Stability and Shelf Life

After the bottle is first opened, the syrup must be used within 3 months (check the specific packaging for regional variations).

Disposal Instructions

Medicines must not be thrown away via household waste or wastewater, as this helps prevent environmental contamination. Unused or expired Prospan Cough Syrup must be returned to a pharmacist or designated medicine collection point for controlled disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Prospan Cough Syrup found in:

A-Z Index: